Observational analysis associates pan-immune-inflammation value with sustained ventricular arrhythmias in NSTEMI, suggesting its potential as an inflammatory risk marker.
Background Systemic inflammation contributes to arrhythmogenesis in acute coronary syndromes, but its role in NSTEMI-related ventricular arrhythmias remains poorly defined. The pan-immune-inflammation value (PIV) is a novel composite biomarker reflecting immune and thrombotic activity derived from routine blood counts. This study aimed to assess the association between PIV and the risk of sustained VT/VF in NSTEMI.
No takes yet. Share an insight, caveat, or question.
Şahin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: